SJIC
CVS icon

St. James Investment Company’s CVS Health CVS Stock Holding History

St. James Investment Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-753,471
Closed -$44.7M – 36
2020
Q1 		$44.7M Buy
753,471
+19,530
+3% +$1.3M 5.62% 4
2019
Q4 		$54.5M Sell
733,941
-32,834
-4% -$2.31M 4.82% 8
2019
Q3 		$48.4M Buy
766,775
+174,824
+30% +$10.4M 4.45% 9
2019
Q2 		$32.3M Sell
591,951
-89,398
-13% -$4.81M 3.1% 12
2019
Q1 		$36.7M Buy
681,349
+26,997
+4% +$1.67M 3.37% 12
2018
Q4 		$42.9M Sell
654,352
-76,369
-10% -$5.7M 4.28% 9
2018
Q3 		$57.5M Sell
730,721
-13,898
-2% -$994K 5.26% 7
2018
Q2 		$47.9M Sell
744,619
-37,466
-5% -$2.47M 5.67% 8
2018
Q1 		$48.7M Sell
782,085
-4,292
-0.5% -$308K 5.88% 6
2017
Q4 		$57M Sell
786,377
-121,057
-13% -$8.8M 6.59% 7
2017
Q3 		$73.8M Buy
907,434
+37,132
+4% +$2.94M 8.3% 2
2017
Q2 		$70M Buy
870,302
+49,242
+6% +$3.89M 8.65% 1
2017
Q1 		$64.5M Buy
+821,060
New +$65.5M 7.77% 4
2014
Q3 		– Sell
-287,302
Closed -$21.7M – 52
2014
Q2 		$21.7M Sell
287,302
-112,857
-28% -$8.53M 2.43% 19
2014
Q1 		$30M Sell
400,159
-76,042
-16% -$5.37M 3.27% 16
2013
Q4 		$34.1M Sell
476,201
-97,958
-17% -$6.29M 3.76% 15
2013
Q3 		$32.6M Sell
574,159
-33,429
-6% -$1.99M 3.66% 15
2013
Q2 		$34.7M Buy
+607,588
New +$35.2M 3.84% 15

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

St. James Investment Company's CVS Position: Q2 2020 in Review

St. James Investment Company sold out of CVS Health (CVS) in Q2 2020, closing a stake of 753,471 shares — an estimated $44.7M sold.

St. James Investment Company first reported a position in CVS in Q2 2013 and held it in 18 quarters. The position peaked at $73.8M in Q3 2017. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • St. James Investment Company reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • St. James Investment Company sold 753,471 CVS Health shares in Q2 2020, an estimated $44.7M.
  • St. James Investment Company first reported a position in CVS Health in Q2 2013 and held it in 18 quarters.
  • St. James Investment Company's CVS Health position peaked at $73.8M in Q3 2017.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on St. James Investment Company's 13F filing for Q2 2020, filed 6 Aug 2020.